NYVEPRIA 6 mg/.6mL
pegfilgrastim-apgf · INJECTION, SOLUTION · Pfizer Laboratories Div Pfizer Inc
NYVEPRIA is a injection, solution containing pegfilgrastim-apgf at 6 mg/.6mL, taken subcutaneous. Manufactured by Pfizer Laboratories Div Pfizer Inc.
Key Facts
- Brand Name
- NYVEPRIA
- Generic Name
- pegfilgrastim-apgf
- NDC Code (Product)
0069-0324- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Strength
- 6 mg/.6mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761111
- Drug Class
- Leukocyte Growth Factor [EPC]
- Marketing Start
- 12/15/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is NYVEPRIA used for?
NYVEPRIA contains pegfilgrastim-apgf. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is NYVEPRIA a controlled substance?
NYVEPRIA is not classified as a controlled substance by the DEA.
What is the generic name for NYVEPRIA?
The generic name for NYVEPRIA is pegfilgrastim-apgf. There are no other listed brand versions of pegfilgrastim-apgf.
What is the NDC code for NYVEPRIA 6 mg/.6mL?
The NDC (National Drug Code) for NYVEPRIA 6 mg/.6mL is 0069-0324, listed by Pfizer Laboratories Div Pfizer Inc.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)